23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement
Share page
Sponsored content

Unlocking the future of medtech

Navigating the European medtech regulatory jungle? Good news —real progress is ahead.

In her latest column in Medtech Magazine, Anna-Karin Alm, Head of QARA at Aurevia, explores how the convergence of regulations, such as the MDR, IVDR and AI Act, are reshaping the path to market for medical devices.  

While today’s regulatory landscape can feel overwhelming for innovators, AI-driven tools and regulatory sandboxes are emerging as game-changers, making compliance more accessible and innovation more achievable. 

Read the full article at Medtech Magazine (in Swedish) to see what’s on the horizon for the future of medtech.

Aurevia
Box 150 27
750 15 Uppsala
Uppsala kommun
Sweden
VAT Number: SE5565873147

Contact Person

Anna-Karin Alm
Head of QARA
anna-karin.alm@aurevia.com
Advertisement Advertisement
BREAKING
{{ article.headline }}
0.093|instance-web01